Entrada Therapeutics (TRDA) Q3 2024 Earnings

13AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.74
0.02
0.79
1.55

Details

Expected EPS
0.36136
Actual EPS
1.55
Surprise EPS
1.19
Surprise Percent
+328.94%

Description

Entrada Therapeutics (TRDA) has reported earnings of 1.55 per share for Q3 2024.

0 Comments

Share your thoughts